Last updated:
Author(s):
Jia You, Xi-Han Cui, Yi-Lin Chen, Yi-Xuan Wang, Hai-Yun Li, Yi-Xuan Qiang, Ji-Yun Cheng, Yue-Ting Deng, Yu Guo, Peng Ren, Yi Zhang, Yu He, Xiao-Yu He, Shi-Dong Chen, Ya-Ru Zhang, Yu-Yuan Huang, Ying Mao, Jian-Feng Feng, Wei Cheng, Jin-Tai Yu
Publish date:
19 September 2025
Journal:
Nature Metabolism
PubMed ID:
40973818

Abstract

A systematic characterization of metabolic profiles in human health and disease enhances precision medicine. Here we present a comprehensive human metabolome-phenome atlas, using data from 274,241 UK Biobank participants with nuclear magnetic resonance metabolic measures. This atlas links 313 plasma metabolites to 1,386 diseases and 3,142 traits, with participants being prospectively followed for a median of 14.9 years. This atlas uncovered 52,836 metabolite-disease and 73,639 metabolite-trait associations, where the ratio of cholesterol to total lipids in large low-density lipoprotein percentage was found as the metabolite associated with the highest number (n = 526) of diseases. In addition, we found that more than half (57.5%) of metabolites showed statistical variations from healthy individuals over a decade before disease onset. Combined with demographics, the machine-learning-based metabolic risk score signified the top 30 (around 10%) metabolites as biomarkers, yielding favourable classification performance (area under the curve > 0.8) for 94 prevalent and 81 incident diseases. Finally, Mendelian randomization analyses provided support for causal relationships of 454 metabolite-disease pairs, among which 402 exhibited shared genetic determinants. Additional insights can be gleaned via an accessible interactive resource (https://metabolome-phenome-atlas.com/).

Related projects

1. What is the primary change of the brain (including functional connectivity, gray matter volume and fiber integrity) for major psychiatric disorders? 2. Are…

Institution:
University of Warwick, Great Britain

Our research project aims to uncover new insights into human diseases and improve patient outcomes by identifying specific markers and potential treatment targets using cutting-edge…

Institution:
Fudan University, China

All projects